Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-27 @ 9:03 AM
Study NCT ID:
NCT04073160
Status:
WITHDRAWN
Last Update Posted:
2020-07-07
First Post:
2019-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder Cancer
Sponsor:
Daniel George, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-27
First Submit QC Date:
None
Study First Post Date:
2019-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-01
Last Update Post Date:
2020-07-07
Last Update Post Date Type:
ACTUAL